BMI OrganBank Announces Head-to-Head Preclinical Data for OrganBank Kidney Platform

WINSTON-SALEM, N.C., April 22, 2026 /PRNewswire/ -- BMI OrganBank®, a developer of integrated organ preservation and assessment systems, today announced the presentation of preclinical data evaluating its OrganBank Kidney platform in head-to-head comparison with current standard-of-care cold storage methods. The study, presented at the American Transplant Congress, demonstrated that BMI OrganBank's room-temperature machine perfusion technology significantly improved kidney viability assessment and extended preservation times compared to traditional cold storage. The data showed enhanced functional metrics and reduced injury markers in organs preserved using the OrganBank platform. "These results validate our approach to maintaining organs in a physiologically active state," said David A. Gerber, MD, Chief Medical Officer of BMI OrganBank. "The ability to assess organ function in real-time during preservation is a game-changer for transplant decision-making."